Fraud case file · COVID-era PPE
The $14.6 Million Glove Deal: Inside the George Monemvasitis and Authentitech Investigation
George Monemvasitis persuaded an Australian investor to provide USD 14.6 million for a purported U.S. government glove transaction. The later explanation, the contradictory dates and the litigation that followed raise the question whether that original deal ever existed as it was described.
In October 2020, an Australian investor transferred approximately USD 14.6 million to Texas-based Authentitech LLC, owned and managed by George Monemvasitis. The investor says Monemvasitis persuaded him that the money would finance a major nitrile-glove transaction for a U.S. government customer.
According to the investor, only about a year later did Monemvasitis say that the government transaction had not materialized and that the government customer had cancelled it in January 2021 because of delivery delays. Monemvasitis then said that, in order to recover and return the investment, he had entered a second glove transaction without informing the investor.
That second transaction was later presented to the investor as a fraud committed against Authentitech, with Monemvasitis portraying himself as a victim of the intermediaries and circumstances. But the documented timeline presents a central contradiction: Authentitech signed the USD 8.398 million American Wellness contract on 21 December 2020, before the reported January 2021 cancellation. The sequence supports the investigative suspicion that the original government deal may never have existed as described and that Monemvasitis used that story to obtain a very large sum from the investor.